| ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform |
Globe Newswire |
07/28 |
07:30 |
| Hubbell Reports Second Quarter 2026 Results |
Globe Newswire |
07/28 |
07:30 |
| Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth |
Globe Newswire |
07/28 |
07:30 |
| Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer |
Globe Newswire |
07/28 |
07:30 |
| PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc. |
Globe Newswire |
07/28 |
07:30 |
| Riot Announces Second Quarter 2026 Earnings Conference Call |
Globe Newswire |
07/28 |
07:30 |
| Judge Consulting Group President and CTO John Battaglia Named to City & State PA’s 2026 “40 in Their 40s” List |
Globe Newswire |
07/28 |
07:26 |
| Lifecore Biomedical Signs Three New Customer Agreements |
Globe Newswire |
07/28 |
07:05 |
| US looks to boost anti-China spending worldwide by hundreds of millions, documents say |
AP Online |
07/28 |
07:04 |
| Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance |
Globe Newswire |
07/28 |
07:00 |
| Interbrand and Clootrack Partner to Launch the Industry’s First AI-Native Brand Experience Operating System |
Globe Newswire |
07/28 |
07:00 |
| Blue Gold Announces Appointment of Andrew Cavaghan as Chairman |
Globe Newswire |
07/28 |
07:00 |
| Employees Can Seek Damages for Wrongful Termination After a Medical Disclosure |
Globe Newswire |
07/28 |
07:00 |
| Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder |
Globe Newswire |
07/28 |
07:00 |
| Lantronix Announces DoD Solution Partnership to Deploy Edge AI Drone Platform in Ukraine |
Globe Newswire |
07/28 |
07:00 |
| Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML |
Globe Newswire |
07/28 |
07:00 |
| Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026 |
Globe Newswire |
07/28 |
07:00 |
| Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus |
Globe Newswire |
07/28 |
07:00 |
| Factorial Sets Date for Second Quarter 2026 Results |
Globe Newswire |
07/28 |
07:00 |
| OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer |
Globe Newswire |
07/28 |
07:00 |
| VR Confirms New IP and Conductivity Anomalies on its Bonita Property Porphyry Copper-Gold Project in Nevada |
Globe Newswire |
07/28 |
07:00 |
| NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026 |
Globe Newswire |
07/28 |
07:00 |
| SunPower Reports Q2’26 Results |
Globe Newswire |
07/28 |
07:00 |
| DoubleDown Interactive to Report 2026 Second Quarter Results on August 11 and Host Conference Call and Webcast |
Globe Newswire |
07/28 |
07:00 |
| YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs |
Globe Newswire |
07/28 |
06:55 |
